Use of nonprescription medications for perceived cardiovascular health.

[1]  C. Hennekens,et al.  An update on aspirin in the primary prevention of cardiovascular disease. , 2003, Archives of internal medicine.

[2]  A. Folsom,et al.  Continued decline in cardiovascular disease risk factors: results of the Minnesota Heart Survey, 1980-1982 and 1985-1987. , 1990, American journal of epidemiology.

[3]  D. Jacobs,et al.  The Minnesota Heart Survey , 2005 .

[4]  Hanyu Ni,et al.  Utilization of Complementary and Alternative Medicine by United States Adults: Results From the 1999 National Health Interview Survey , 2002, Medical care.

[5]  U. P. S. T. Force.  Aspirin for the primary prevention of cardiovascular events: recommendations and rationale. , 2002, The American journal of nursing.

[6]  M. Nichter,et al.  Changing patterns of pharmaceutical practice in the United States. , 1997, Social science & medicine.

[7]  W. Frishman,et al.  Herbal medicine for the treatment of cardiovascular disease: clinical considerations. , 1998, Archives of internal medicine.

[8]  J. Hsia,et al.  Effects of hormone replacement therapy and antioxidant vitamin supplements on coronary atherosclerosis in postmenopausal women: A randomized controlled trial , 2002 .

[9]  C. Mulrow,et al.  Garlic: effects on cardiovascular risks and disease, protective effects against cancer, and clinical adverse effects. , 2000, Evidence report/technology assessment.

[10]  A. Mitchell,et al.  Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey. , 2002, JAMA.

[11]  Adriane Fugh-Berman,et al.  Herb-drug interactions , 2000, The Lancet.

[12]  E. Giardina,et al.  Benefits, adverse effects and drug interactions of herbal therapies with cardiovascular effects. , 2002, Journal of the American College of Cardiology.

[13]  R. Kessler,et al.  Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. , 1998, JAMA.

[14]  G. Gazelle,et al.  Analysis of Aspirin-Associated Risks in Healthy Individuals , 2005, The Annals of pharmacotherapy.

[15]  M. Ackman,et al.  Use of OTC and Herbal Products in Patients with Cardiovascular Disease , 2003, The Annals of pharmacotherapy.

[16]  M. Smyer,et al.  Validation of two methods of data collection of self-reported medicine use among the elderly. , 1988, The Gerontologist.

[17]  O. Heinonen,et al.  Increased tendency towards gingival bleeding caused by joint effect of alpha-tocopherol supplementation and acetylsalicylic acid. , 1998, Annals of medicine.

[18]  U. P. S. T. Force.  Routine Vitamin Supplementation To Prevent Cancer and Cardiovascular Disease: Recommendations and Rationale , 2003, Annals of Internal Medicine.

[19]  J. Hanlon,et al.  Use of medications by persons 65 and over: data from the established populations for epidemiologic studies of the elderly. , 1992, Journal of gerontology.

[20]  L. Balluz,et al.  Vitamin and mineral supplement use in the United States. Results from the third National Health and Nutrition Examination Survey. , 2000, Archives of family medicine.

[21]  E. Topol,et al.  A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease. , 2003, Journal of the American College of Cardiology.

[22]  U. P. S. T. Force.  Routine vitamin supplementation to prevent cancer and cardiovascular disease. , 2003, Nutrition in clinical care : an official publication of Tufts University.

[23]  J. Hanlon,et al.  Drug-Use Patterns among Black and Nonblack Community-Dwelling Elderly , 1992, The Annals of pharmacotherapy.

[24]  Kathleen M. Fairfield,et al.  Vitamins for chronic disease prevention in adults: scientific review. , 2002, JAMA.

[25]  A. Folsom,et al.  Recent trends in acute coronary heart disease--mortality, morbidity, medical care, and risk factors. The Minnesota Heart Survey Investigators. , 1996, The New England journal of medicine.

[26]  E. Topol,et al.  Profile and prevalence of aspirin resistance in patients with cardiovascular disease. , 2001, The American journal of cardiology.

[27]  Denise D. Hermann,et al.  Naturoceutical Agents in the Management of Cardiovascular Disease , 2002, American journal of cardiovascular drugs : drugs, devices, and other interventions.

[28]  P. Savage,et al.  Assessing the use of medications in the elderly: methods and initial experience in the Cardiovascular Health Study. The Cardiovascular Health Study Collaborative Research Group. , 1992, Journal of clinical epidemiology.

[29]  Linda P. Fried,et al.  The Women's Health and Aging Study: Health and Social Characteristics of Older Women with Disability , 1995 .

[30]  K. Schrör,et al.  Functional and Biochemical Evaluation of Platelet Aspirin Resistance After Coronary Artery Bypass Surgery , 2003, Circulation.

[31]  U. P. S. T. Force,et al.  Measuring Quality: Are We Ready To Compare the Quality of Care among Physician Groups? , 2002, Annals of Internal Medicine.

[32]  Robert H. Fletcher,et al.  Vitamins for Chronic Disease Prevention in Adults , 2002 .

[33]  H. Reuter.  Allium sativum and Allium ursinum: Part 2 pharmacology and medicinal application. , 1995, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[34]  A. Folsom,et al.  Population risk of cardiovascular disease: the Minnesota Heart Survey. , 1985, Journal of chronic diseases.